HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2006.118646v1 56/9/1240    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nuding, S. Articles by Stange, E. F Search for Related Content PubMed PubMed Citation Articles by Nuding, S. Articles by Stange, E. F Topic Collections Related Article

Reduced mucosal antimicrobial activity in Crohn’s disease of the colon

¹ Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
² Department of Internal Medicine I, Robert-Bosch-Hospital, Stuttgart, Germany

Correspondence to:
Correspondence to:
Sabine Nuding
PhD, Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstr. 112, 70376 Stuttgart, Germany; Sabine.Nuding{at}ikp-stuttgart.de

Objectives: In order to maintain the mucosal barrier against luminal microorganisms the intestinal epithelial cells synthesise various broad-spectrum antimicrobial peptides including defensins and cathelicidins. Recent studies indicate that both may be deficient in Crohn’s disease. To elucidate the possible functional consequences of this deficiency antimicrobial activity in colonic mucosa from patients with inflammatory bowel disease and healthy controls was investigated.

Methods: A flow cytometric assay was established to quantitate bacterial killing and test the antibacterial activity of cationic peptide extracts from colonic biopsies taken from patients with active or inactive ileocolonic or colonic Crohn’s disease (n = 22), ulcerative colitis (n = 29) and controls (n = 13) against clinical isolates of Bacteroides vulgatus and Enterococcus faecalis or the reference strains Escherichia coli American Type Culture Collection (ATCC) 25922 and Staphylococcus aureus ATCC 25923.

Results: Compared with controls and ulcerative colitis there was a reduced antimicrobial effect in Crohn’s disease extracts that was most evident against B. vulgatus. The antimicrobial effect against E. coli and E. faecalis was significantly lower in Crohn’s disease compared with ulcerative colitis. Activity against S. aureus disclosed a similar pattern, but was less pronounced. The differences were independent of the inflammation status or concurrent steroid treatment. Bacteria incubated with biopsy extracts from ulcerative colitis patients frequently showed a characteristic change in cell size and granularity, compatible with more extensive membrane disintegration, compared with bacteria incubated with extracts from controls or Crohn’s disease.

Conclusion: Crohn’s disease of the colon is characterized by a diminished functional antimicrobial activity that is consistent with the reported low antibacterial peptide expression.

Abbreviations: ATCC, American Type Culture Collection; DiBAC₄(3), [bis-(1,3-dibutylbarbituric acid) trimethine oxonol]; HBD, human ß-defensin; HD, human defensin

Related Article

Digest

Robin Spiller and Emad El-Omar
Gut 2007 56: 1177. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				E. F Stange and S. P L Travis The European consensus on ulcerative colitis: new horizons? Gut, August 1, 2008; 57(8): 1029 - 1031. [Full Text] [PDF]

				U. Meyer-Hoffert, M. Hornef, B. Henriques-Normark, S. Normark, M. Andersson, and K. Putsep Identification of heparin/heparan sulfate interacting protein as a major broad-spectrum antimicrobial protein in lung and small intestine FASEB J, July 1, 2008; 22(7): 2427 - 2434. [Abstract] [Full Text] [PDF]

				S. Subramanian, C. L. Roberts, C. A. Hart, H. M. Martin, S. W. Edwards, J. M. Rhodes, and B. J. Campbell Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics Antimicrob. Agents Chemother., February 1, 2008; 52(2): 427 - 434. [Abstract] [Full Text] [PDF]

				J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]

				A. M. Scanu, T. J. Bull, S. Cannas, J. D. Sanderson, L. A. Sechi, G. Dettori, S. Zanetti, and J. Hermon-Taylor Mycobacterium avium Subspecies paratuberculosis Infection in Cases of Irritable Bowel Syndrome and Comparison with Crohn's Disease and Johne's Disease: Common Neural and Immune Pathogenicities J. Clin. Microbiol., December 1, 2007; 45(12): 3883 - 3890. [Abstract] [Full Text] [PDF]